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Inhibition of NF-κB in astrocytes is
sufficient to delay neurodegeneration
induced by proteotoxicity in neurons
Y. X. Li1, O. C. M. Sibon1 and P. F. Dijkers1,2*
Abstract
Background: Most neurodegenerative diseases associated with protein aggregation are hallmarked by activation of
astrocytes. However, how astrocytes are activated or which signaling pathways in astrocytes contribute to pathogenesis is
not clear. One long-standing question is whether the responses in astrocytes are due to stress or damage in astrocytes
themselves, or because of astrocytic responses to cellular stress or damage in neurons. Here, we examine responses in
astrocytes induced by expression of disease-associated, aggregation-prone proteins in other cells. We also examine the
consequences of these responses in astrocytes in a model for neurodegeneration.
Methods: We first examined a role for intracellular astrocytic responses in a Drosophila model for Spinocerebellar ataxia
type 3 (SCA3, also known as Machado–Joseph disease), a disease caused by expansion of the polyglutamine (polyQ)
stretch in the ATXN3 gene. In this Drosophila SCA3 model, eye-specific expression of a biologically relevant portion of the
ATXN3 gene, containing expanded polyQ repeats (SCA3polyQ78) was expressed. In a candidate RNAi screen in the
Drosophila SCA3 model, we analyzed whether downregulation of expression of specific genes in astrocytes affected
degeneration induced by SCA3polyQ78 expression in Drosophila eyes. We next examined the role of astrocytes in
response to proteotoxic stress in neurons induced by SCA3polyQ78 expression or amyloid beta peptides, associated
with Alzheimer’s disease.
Results: Eye-specific expression of SCA3polyQ78 resulted in the presence of astrocytes in the eye, suggesting
putative involvement of astrocytes in SCA3. In a candidate RNAi screen, we identified genes in astrocytes that can
enhance or suppress SCA3polyQ78-induced eye degeneration. Relish, a conserved NF-κB transcription factor, was
identified as an enhancer of degeneration. Activity of Relish was upregulated in our SCA3 model. Relish can exert
its effect via Relish-specific AMPs, since downregulation of these AMPs attenuated degeneration. We next examined
Relish signaling in astrocytes on neurodegeneration. Selective inhibition of Relish expression specifically in astrocytes
extended lifespan of flies that expressed SCA3polyQ78 exclusively in neurons. Inhibition of Relish signaling in astrocytes
also extended lifespan in a Drosophila model for Alzheimer’s disease.
(Continued on next page)
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Conclusions: Our data demonstrate that astrocytes respond to proteotoxic stress in neurons, and that these astrocytic
responses are important contributors to neurodegeneration. Furthermore, our data demonstrate that activation of
NF-κB transcription factor Relish in astrocytes, induced by proteotoxic stress in neurons, enhances neurodegeneration,
and that specific Relish inhibition in astrocytes extends lifespan. Our data provide direct evidence for cell-non-autonomous
contributions of astrocytes to neurodegeneration, with possible implications for therapeutic interventions in multiple
neurodegenerative diseases.
Keywords: Neurodegeneration, Astrocytes, NF-κB, Cell-non-autonomous, Drosophila, Polyglutamine diseases, Spinocerebellar
ataxia, Neuroimmunology
Background
A hallmark of many age-related neurodegenerative dis-
eases is the presence of protein aggregates, which pre-
cedes the onset of clinical symptoms. Genetic profiling
of transcriptional changes in neurodegenerative dis-
eases resulted in the identification of glial genes whose
altered expression could potentially contribute to
pathogenesis [1, 2]. Besides this, another characteristic
in most, if not all neurodegenerative diseases associated
with protein aggregation is the activation of astrocytes
[3]. Recently, it was demonstrated that a subtype of as-
trocytes is neurotoxic and is present in most neurode-
generative diseases [4].
The presence of aggregates in astrocytes can result in
their activation and subsequent signaling to neurons [5];
reviewed in [6]. However, it is unclear whether signals
from aggregate-expressing neurons can modulate the ac-
tivity of astrocytes. Furthermore, the putative conse-
quences of signaling from astrocytes that are activated
by neuronal proteotoxic stress on the functioning of
neurons are not known.
Astrocytes are involved in essential CNS functions, in-
cluding metabolic functions, regulating levels of neuro-
transmitters, maintaining the blood-brain barrier, as well
as immune defense, thus contributing to neuronal
homeostasis [7]. Astrocytes are activated early in neuro-
degenerative diseases at times that may precede the
appearance of aggregates [6]. This activation only occurs
in specific areas of the brain, i.e., those that are primarily
affected by the respective diseases, such as for example
the striatum in Huntington’s disease (HD), the pons in
SCA3, and the cortex in Alzheimer’s disease (AD) [8, 9].
Alterations in function of astrocytes can contribute to
pathogenesis in a mouse model for HD, and therefore
astrocytes have been suggested as potential therapeutic
targets [10]. In this model, the HD-associated,
aggregation-prone protein was amongst others expressed
in the brain, including neurons, microglia, and astro-
cytes. Thus, in this model, cell-autonomous activation of
astrocytes (in response to proteotoxic stress) as well as
cell-non-autonomous activation of astrocytes (in re-
sponse to proteotoxic stress in neurons) could
contribute to pathogenesis. There is ample evidence of
cell-autonomous activation of astrocytes in the patho-
genesis of neurodegenerative diseases (reviewed in [6,
11]). However, how signaling from aggregate-expressing
neurons can influence signaling in astrocytes and how
responses from astrocytes can modulate neurodegenera-
tion is unknown.
We investigated if and how astrocytes contribute to
neurodegenerative diseases in a cell-non-autonomous
manner, within the context of an intact animal. Examining
astrocytes in an in vivo model is key, given that their
morphology and activity change when taken outside their
physiological context (reviewed in [12]). For this, we con-
ducted a dedicated RNAi screen to selectively knock down
individual genes in astrocytes in a Drosophila melanoga-
ster model of the polyQ disease SCA3. In SCA3, the
ATXN3 gene contains an expanded CAG repeat (coding
for glutamine) that leads to the expression of a misfolded,
aggregation-prone ATXN3 polyglutamine protein. These
misfolded polyQ-containing proteins accumulate intracel-
lularly, resulting in neuronal damage and activation of
astrocytes [13]. In the brains of patients as well as of ani-
mal models, proteolytic cleavage of a fragment of the gene
containing the polyQ-containing stretch can mediate the
toxicity of expanded polyQ [14–16]. We expressed this
biologically relevant, truncated part of the ATXN3 gene
containing an expanded polyQ stretch (SCA3polyQ78)
exclusively in Drosophila eyes and simultaneously
downregulated expression (by RNAi) of candidate genes
exclusively in astrocytes. This setup would provide insight
into the putative cell-non-autonomous contributions of
astrocytes to neurodegeneration induced by proteotoxicity
in neurons. In a candidate RNAi screen, we identified
genes in astrocytes that cell-non-autonomously influenced
degeneration. This demonstrates the relevance of cell-
non-autonomous signaling in astrocytes in neurodegener-
ation. We further explored the contribution of NF-κB
transcription factor Relish, which was identified as an
enhancer in our screen, and its activity was upregu-
lated in our SCA3 model. We investigated the role of
Relish in astrocytes in SCA3, as well as in a model
for Alzheimer’s disease.
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Methods
Drosophila strains
All fly lines were maintained at 25 °C on standard fly food
unless indicated otherwise. The following stocks were ob-
tained from the Bloomington Drosophila stock center
(BDSC, Bloomington, Indiana, U.S.A.): UAS-MJD.tr-Q27
(8149), UAS-MJD.tr-Q78 (8150), QUAS-mCD8-GFP
(30003), UAS myr-RFP (7118), two tub-QS lines (52112
and 30024), alrm-Gal4 (67031); GMR-Gal4 (1104); daugh-
terless-Gal4 (8641); UAS-Relish RNAi #2 (33661); Relish
E20 mutant (9457). The following stocks were from
Vienna Drosophila Research Center (VDRC): UAS-Relish
RNAi #1 (49414-GD), UAS-Attacin A RNAi (50320-GD),
UAS-Cecropin A (42859-GD). The stocks used in
the screen are all from VDRC. UAS-GFP-Relish has been
described [17]. GMR-QF2 (BDSC #59283) nSyb-QF2
(BDSC 51956), the CyO-tub-QS balancer as well as the
pQUAST vector were a gift from C. Potter (Baltimore,
MD, USA). UAS-necrotic-Abeta42 flies were a gift from D.
Crowther (Cambridge University, Cambridge, United
Kingdom) and have been described previously [18]. All
flies were backcrossed to w1118 flies. We generated
QUAST-SCA3polyQ27 and QUAST-SCA3polyQ78 transgenic
flies by amplifying the corresponding cDNA from gDNA
of stock #8149 (UAS-SCA3polyQ27) or #8150 (UAS-SCA3-
polyQ78), using the following UAS-specific primers: 5′-
ATAGGGAATTGGGAATTCGTT-3′ and 5′- CAAT
TATGTCACACCACAGAA-3′ and cloned into pUAST
using EcoRI and XbaI. We generated pQUAST-necroti-
c-Aβ42 by amplifying from gDNA from UAS-necrotic-A-
beta42 flies using 5′-cgaattcaacATGgcgagcaaagtctcgatc-3′
and 5’-ctctagaTTACGCAATCACCACGCCGC-3′ and
cloned into pQUAST using EcoRI and XbaI. Constructs
were verified by sequencing. Transgenic fly lines were
generated in the w1118 background, using BestGene
(Chino Hills, CA, USA).
Genetics
To independently and simultaneously manipulate gene
expression in either the eyes or neurons, or astrocytes,
we used the QUAS-QF system to express constructs in
neurons or in the eyes and UAS-Gal4 to manipulate
gene expression in astrocytes (using alrm-Gal4). We
suppressed QF-dependent expression by expressing QS
under control of the tubulin promoter. A schematic
drawing of the genetic systems involved is shown in
Additional files 1a and 7b. To analyze
astrocyte-associated genes in SCA3polyQ78-induced eye
degeneration, we used the following fly line: GMR-QF2/
(Y); QUAS-SCA3polyQ78:: alrm-Gal4/CyO-tub-QS. In this
line, expression of SCA3polyQ78 is suppressed by QS,
which inhibits QF2. To analyze genes in astrocytes on
the degenerative SCA3 eye phenotype, we crossed this
line to different UAS constructs. To quantify eye
degeneration by analyzing levels of mCD8-GFP, we used
the line GMR-QF2/(Y); QUAS-SCA3polyQ78/CyO-tub-QS:
alrm-Gal4: QUAS-mCD8-GFP, and crossed them to UAS
lines or w1118 flies. The data depicted are all from female
flies, although male flies yielded similar results. To analyze
the effect of SCA3polyQ78 in neurons and a possible effect
of astrocytes on the SCA3polyQ78-induced pathogenesis,
we used the following line: tub-QS/(y); QUAS-SCA3po-
lyQ78:: alrm-Gal4; nSyb-QF2: tub-QS. We used two copies
of tub-QS, since one copy was not able to suppress the ex-
pression of SCA3polyQ78. We supplemented adult flies with
quinic acid to suppress QS and allow expression of SCA3-
polyQ78 only in adulthood. Data of females are depicted, al-
though data in males yielded similar results.
Analysis of eye degeneration
For each line we analyzed, we calculated the fraction of
the eyes that showed a SCA3polyQ78-induced degenerative
phenotype (necrotic spots) as shown previously [19] of at
least 40 flies. The data of eye degeneration that are shown
are all of female flies, although male flies yielded similar
results. In all the figures, the percentage of eye degener-
ation is calculated as the fraction of the eyes containing
necrotic spots. The results were average of at least three
independent experiments −/+SEM. *p < 0.05; **p < 0.01.
Real-time quantification PCR (RT-qPCR)
We collected 120 fly heads per point to isolate total RNA
using the RNeasy Mini Kit (Qiagen). To collect the heads,
flies were frozen in liquid nitrogen and decapitated by vor-
texing. Fly heads were collected using a mesh. M-MLV re-
verse transcriptase (Invitrogen, 28025-013) was used to
transcribe RNA into cDNA. Relative quantification of the
gene expression level was determined in CFX ConnectTM
(Bio-Rad) by using iQTM SYBR® Green Supermix
(Bio-Rad Laboratories, Inc.). For all the samples, gene ex-
pression levels were normalized to a housekeeping gene,
ribosomal protein 49 (RP49). Analysis of knockdown of
gene expression was determined in adult flies.


















Results are average of at least three independent experi-
ments −/+SEM. *p < 0.05; **p < 0.01; ***p < 0.001.
Western blotting
For examining HA-tagged SCA3polyQ27 or SCA3polyQ78
levels and aggregation and their effect on eye viability
(using CD8-GFP), 2-day-old flies were used. At least 30
fly heads per genotype were collected, lysed in Laemli
buffer by sonification, and boiled at 95 °C for 5 min.
Samples were separated on 12.5% SDS-PAGE gels and
transferred to PVDF membranes (Millipore, Fisher Sci-
entific). After blocking in 5% (w/v) non-fat dried milk in
PBST for 1 h, the membrane was incubated with primary
antibody overnight at 4 °C. The following are antibodies
were used: rat anti-HA-Peroxidase (Roche Diagnostics
GmbH, Germany), rabbit anti-GFP (A11122; Invitrogen)
mouse anti-RFP (6G6 ChromoTek) 6E10 Ab was pur-
chased from Covenance and mouse anti-alpha tubulin
from Sigma (T5138). After incubation with secondary
antibody, ECL (Amersham) signal was detected in a
ChemiDocTM Touch (Bio-Rad). The intensity of the
bands was analyzed by using ImageJ (National Institutes
of Health, USA). Quantification of western blots was of
at least three independent experiments unless indicated
otherwise, *p < 0.05; **p < 0.01.
Lifespans
To determine the lifespan of flies, a maximum of 20 flies
was kept in a vial. At least 80 flies per condition were
analyzed. Every 2 days flies were transferred into new
vials containing fresh food. Data are representative of
female flies, although similar results were obtained with
males. The following fly lines were used to determine
the effect of genes in astrocytes on survival: (1) tub-QS/
(y); QUAS-SCA3polyQ78:: alrm-Gal4/CyO; nSyb-QF2::
tub-QS/TM6B (SCA3polyQ78 line), (2) tub-QS/(y);
alrm-Gal4/CyO; nSyb-QF2: tub-QS/TM6B (control line
for SCA3polyQ78), (3) QUAS-necrotic-Abeta42:: alrm-Gal4/
CyO-QS; nSyb-QF2 (Abeta42 line), and (4) alrm-Gal4/
CyO-QS; nSyb-QF2 (control line for Abeta42). These lines
were used to test the effect of astrocyte-specific genes on
flies that express SCA3polyQ78 in neurons in adulthood or
Abeta42 peptides. Expression of SCA3polyQ78 was induced
in neurons of adult flies by inhibiting QS through supple-
menting the food with quinic acid. Quinic acid was used
in a concentration of 250 mg/ml with fixed pH of
7. 250 μl of quinic acid solution was put on top of the food
to cover the entire surface and used when the solution
was completely absorbed into the food [20]. Lifespan
curves were analyzed in GraphPad Prism (GraphPad Soft-
ware, San Diego, CA, USA) and statistical significance was
analyzed by Log-rank (Mantel-Cox) test.
Climbing assay
For each cross, 5 vials of flies, containing a maximum of
20 flies per vial, were analyzed. Here, we analyzed males,
as the climbing ability in females varies more between the
individuals of a group. To determine the mobility of flies,
we analyzed their climbing ability. For this, the vial was di-
vided into four compartments, with the lowest compart-
ment numbered with 1 (slow climbers) and the highest
with number 4 (fast climbers). Flies were tapped down to
the bottom of vials and were allowed 10 s to climb up,
after which a picture was taken. The numbers of flies in
each compartment were counted for each time point. To
get better separation of the differences, flies in compart-
ment 1 got a score of 1; flies in compartment 2 got a score
of 3; flies in compartment 3 got a score of 5, and flies in
compartment 4 got a score of 7. Subsequently, the average
score of each time point was determined by dividing the
total score by the total number of flies. The climbing test
was repeated three times for each group, and the average
of the three times was shown.
Drosophila brain and microscopy
Heads of Drosophila females were collected in ice-cold PBS,
fixed in 3.7% formaldehyde solution (0.1% triton x-100 in
PBS) for 15 min, and washed five times in PBS. Next, Dros-
ophila brains were dissected in PBS and stained with DAPI
solution (0.2 mg/ml, 2% BSA and 0.1% Triton x-100 in
PBS) at room temperature. After washing with PBS for
three times, the brains were mounted in 80% glycerol on
slides and imaged by a Leica SP8 confocal microscope.
Results
Expression of a biologically relevant, truncated form of
the human ATXN3 gene containing an expansion of the
glutamine region (trSCA3 Q78, containing 78 glutamines,
hereafter referred to as SCA3polyQ78) in Drosophila eyes re-
sulted in progressive degeneration of photoreceptor cells
[21], accompanied by eye depigmentation as well as
depigmentation accompanied by black necrotic spots
(depigmented and necrotic, Fig. 1a; arrow indicates nec-
rotic spots). No such effects were seen in control eyes or
eyes expressing SCA3polyQ27, containing a non-pathogenic
length of glutamines (SCA3polyQ27; Fig. 1a) [21]. Quantifi-
cation of the fraction of the eyes with a normal appear-
ance, displaying depigmentation or necrotic spots is
shown in Fig. 1b. Only expression of SCA3polyQ78 resulted
in depigmentation or necrotic spots. We quantified the
extent of degeneration by determining the fraction of the
eyes containing necrotic spots. This quantification pro-
vides a quick and reproducible means of analysis. To see



































































































































































Fig. 1 (See legend on next page.)
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whether SCA3polyQ78-induced degeneration was accompan-
ied by decreased solubility of SCA3polyQ78, lysates of fly
heads were analyzed. Expression of SCA3polyQ78 but not
SCA3polyQ27 resulted in the presence of high molecular
weight insoluble proteins (Fig. 1c), which have previ-
ously been identified as aggregates using immunofluor-
escence [22].
We used another robust, sensitive way to quantify de-
generation, by coexpressing membrane-targeted mCD8-
GFP [23] with SCA3polyQ27 or SCA3polyQ78 in the eyes.
Expression of SCA3polyQ78 but not SCA3polyQ27 resulted in
a decrease of mCD8-GFP levels, indicative of degeneration
(Fig. 1d, top panel). Analysis of mCD8-GFP expression
levels in SCA3polyQ78-expressing eyes in lysates of fly heads
allows for quantification of degeneration (Fig. 1e). Both
the fraction of necrotic eyes and GFP levels were used as
readouts to determine the effect of downregulation of spe-
cific genes in astrocytes on degeneration.
To analyze a putative cell-non-autonomous role for as-
trocytes in SCA3polyQ78-induced eye degeneration, we used
two binary expression systems that act independently [20],
UAS-Gal4 and QUAS-QF2 (Additional file 1a). Indeed,
expression of fluorescent proteins in astrocytes (RFP) or
the eyes (GFP) shows specific non-overlapping expression
in the respective tissues (Additional file 1b). We analyzed
whether the location of astrocytes (expressing RFP) was
altered upon expression of SCA3polyQ78 in the eyes. We
observed the presence of astrocytes in SCA3polyQ78-ex-
pressing eyes but not in control eyes or eyes expressing
SCA3polyQ27 (Fig. 1d, bottom panel). The response in
SCA3polyQ78-expressing flies is quite robust, as they all dis-
played expression of RFP in the eyes (Additional file 2).
The number of astrocytes in all samples in Fig. 1d is com-
parable, as total RFP levels in fly heads were similar
(Fig. 1e). Thus, the presence of astrocytes in SCA3poly-
Q78-expressing eyes suggests a response in astrocytes,
which warrants further investigation into a putative
cell-non-autonomous role of astrocytes in degeneration.
Our Drosophila SCA3 model allows specific analysis of
cell-non-autonomous contributions of astrocytes to the
degenerative SCA3 eye phenotype. We selected genes
(many of them evolutionarily conserved; Additional file 3)
potentially involved in (1) communication between neu-
rons and astrocytes, such as neuropeptides and their
cognate receptors (2) immune signaling pathways, such
as nuclear factor kappa B (NF-κB) and (3) potential re-
ceptors for cytokines, neuropeptides, aggregates, or
damage-associated molecular patterns. Some of the
genes that were selected have either been implicated in
cell-autonomous activation of astrocytes [6] or are up-
regulated in the degenerative fly brain [24, 25]. However,
the role of these genes in cell-non-autonomous activa-
tion of astrocytes in response to proteotoxic stress in
neurons and subsequent contribution to neurodegenera-
tion still remained to be determined. In a candidate
RNAi screen, RNAi constructs targeting a set of 156 se-
lected genes were expressed exclusively in astrocytes in
flies expressing SCA3polyQ78 exclusively in the eyes, and
the extent of eye degeneration was analyzed by deter-
mining the fraction of necrotic spots. The screen re-
vealed both suppressors (n = 26; RNAi against these
genes enhanced degeneration) as well as enhancers (n = 20;
RNAi against these genes reduces degeneration) of the
SCA3 eye phenotype (Additional file 3). These results
underscore the relevance of astrocytes in the progression of
SCA3polyQ78-induced eye degeneration.
One of the genes identified in the screen was NF-κB
transcription factor Relish (orthologous to mammalian
NF-κB1). Downregulation of Relish expression by RNAi,
but also downregulation of several other genes in the
Relish pathway, suppressed the SCA3 phenotype. While
NF-κB has been implicated in activation of astrocytes in
neurodegeneration (reviewed in [6, 26]), a
cell-non-autonomous role of NF-κB activation in astro-
cytes through signals from neurons and subsequent ef-
fect on neurodegeneration remains to be determined. In
(See figure on previous page.)
Fig. 1 Analysis and quantification of the effects induced by expression of SCA3polyQ78. a Representative pictures of a control eye, and eyes
expressing SCA3polyQ27 or SCA3polyQ78. Expression of SCA3polyQ78 but not SCA3polyQ27 in Drosophila eyes resulted in loss of pigment (“depigmented”),
as well as the presence of necrotic patches (“necrotic”, indicated with arrow). b Quantification of the fraction of the eyes as shown in a that have
a normal appearance, display a loss of pigment or contain necrotic patches; the fraction of SCA3polyQ78 eyes containing necrotic patches was used
as a quantitative measure for degeneration. Data are representative of at least three independent experiments. SEM = 0.863. c Western blot analysis of
fly head lysates expressing eye-specific, HA-tagged SCA3polyQ27, or SCA3polyQ78. A fraction of SCA3polyQ78 but not SCA3polyQ27 was SDS-insoluble.
Tubulin was used as a control for equal loading. d Expression of mCD8-GFP in the eye to analyze SCA3polyQ78-induced eye degeneration and analysis
of SCA3polyQ78 expression on the localization of astrocytes (expressing RFP). Top panel: GFP fluorescence of a representative control eye or eyes
coexpressing SCA3polyQ27 or SCA3polyQ78. Bottom panel: the localization of myr-RFP-expressing (RFP) astrocytes was analyzed in control eyes or eyes
expressing SCA3polyQ27, or SCA3polyQ78. e Lysates of control flies or flies expressing mCD8-GFP in the eyes and myr-RFP in astrocytes together in the
absence or presence of SCA3polyQ27 or SCA3polyQ78 were analyzed for expression of HA-tagged SCA3, GFP, and RFP. Tubulin was used as an equal
loading control. Genotypes in a–c: control, GMR-QF2/+. SCA3polyQ27, GMR-QF2/+; QUAS-SCA3polyQ27/+. SCA3polyQ78, GMR-QF2/+; QUAS-SCA3polyQ78/+.
Genotypes in d, top panel: control, GMR-QF2/+; QUAS-mCD8-GFP/+. SCA3polyQ27, GMR-QF2/+; QUAS-SCA3polyQ27/+; QUAS-mCD8-GFP/+. SCA3polyQ78:
GMR-QF2/+; QUAS-SCA3polyQ78/+; QUAS-mCD8-GFP/+. Bottom: control, GMR-QF2/+; alrm-Gal4::UAS-myr-RFP/+. SCA3polyQ27, GMR-QF2/+; alrm-Gal4::UAS-
myr-RFP/QUAS-SCA3polyQ27. SCA3polyQ78: GMR-QF2/+; alrm-Gal4::UAS-myr-RFP/QUAS-SCA3polyQ78. Genotypes in e: as in d except that, where indicated,
both QUAS-mCD8-GFP (eyes) or alrm-Gal4::UAS-myr-RFP (astrocytes) were expressed
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Drosophila, there are two independent NF-κB pathways,
activating transcription factors Relish or Dif/Dorsal re-
spectively. We examined expression of anti-microbial pep-
tides (AMPs) in our SCA3 model, transcriptional NF-κB
targets which help fight infection [27]. In inflammatory re-
sponses, these peptides are considered to aid in activating
and recruiting immune cells (reviewed in [28]). While
both NF-κB pathways are activated upon eye-specific ex-
pression of SCA3polyQ78, activation of Relish was stronger:
AMPs specific for Relish (CecA and DptA) were upregu-
lated more than Dif/Dorsal-specific AMPs (IM1 and IM2;
Fig. 2a and shown in [29]). Activation of Relish in SCA3po-
lyQ78-expressing eyes occurred in astrocytes: GFP under
control of the promoter of a Relish-dependent gene was
expressed predominantly in the astrocytes that were
present in SCA3polyQ78-expressing eyes (Additional file 4a).
In control eyes, no induction of GFP was seen.
We further focused on the cell-non-autonomous role of
astrocyte-specific Relish signaling in SCA3. We first con-
firmed the results of our screen by using two independent
Relish RNAi constructs (efficacy of knockdown, see
Additional file 4b) that both decreased SCA3polyQ78-in-
duced degeneration (Fig. 2b). Inversely, the opposite effect
was seen upon overexpression of Relish. Modulation of
Relish expression in astrocytes did not affect morphology
of control eyes (Additional file 4c). In flies heterozygous
for Relish, degeneration was attenuated, similar to
astrocyte-specific Relish RNAi. The effect of Relish in as-
trocytes on eye degeneration was quantified (Fig. 2c) by
determining the fraction of the eyes containing necrotic
spots. Importantly, the effects of Relish on degeneration
are cell-non-autonomous, mediated via astrocytes: when
coexpressing SCA3polyQ78 and RNAi constructs targeting
Relish in the eyes, eye degeneration was not attenuated
(Additional file 4d).
When membrane-targeted mCD8-GFP was used as a
readout for degeneration [23] in eyes expressing SCA3po-
lyQ78, the protective or enhancing effects of the
astrocyte-specific down- and upregulation of Relish
levels were confirmed (Fig. 2d for GFP images of differ-
ent genotypes). To see whether modulating of Relish ex-
pression in astrocytes affected the localization of
astrocytes, we coexpressed myr-RFP in astrocytes. We
did not see an effect of modulation of Relish expression
on the localization of the RFP signal (Fig. 2d for RFP im-
ages of different genotypes, Fig. 2f for western blot ana-
lysis of lysates). These data suggest that Relish in
astrocytes does not have an effect on the localization of
astrocytes in SCA3polyQ78-expressing eyes (additional im-
ages are provided in Additional file 4e). We quantified
the effect of modulating Relish expression in astrocytes
on mCD8-GFP levels in SCA3polyQ78-expressing eyes by
western blot (Fig. 2e). GFP levels in flies heterozygous
for Relish were similar to those of Relish RNAi in
astrocytes, suggesting the importance of astrocyte-spe-
cific Relish signaling in SCA3polyQ78-induced degener-
ation. The effect of Relish on mCD8-GFP levels in the
eye is specifically related to SCA3polyQ78-induced degen-
eration, as in control flies (not expressing SCA3polyQ78)
GFP levels were similar, irrespective of Relish expression
(Additional file 4f). Together, these experiments
demonstrate that in our SCA3 model, Relish is activated
(and Dif/Dorsal to a lesser extent) and that Relish signaling
in astrocytes enhances SCA3polyQ78-induced degeneration.
Thus, eye-specific expression of SCA3polyQ78 promoted
Relish activation in astrocytes, and this Relish activation en-
hanced degeneration in a cell-non-autonomous manner.
In the brain, Relish is activated in glia in aging flies as
well as in flies that are mutant for A-T mutated (ATM), a
kinase associated with ensuring genomic integrity and
neurodegeneration [30, 31]. We analyzed contribution of
astrocytes to overall Relish signaling in the fly head in-
duced by eye-specific expression of SCA3polyQ78. For this,
we examined levels of Relish-dependent AMPs in fly
heads expressing SCA3polyQ78 in the eyes together with
astrocytes-specific targeting of Relish RNAi or Relish over-
expression constructs, or in SCA3polyQ78-expressing flies
heterozygous for Relish. Expression of Relish RNAi con-
structs in astrocytes in flies expressing eye-specific SCA3-
polyQ78 resulted in decreased expression of Relish-specific
AMPs (DptA and AttC) in the head to levels comparable
to flies not expressing SCA3polyQ78 (Fig. 3a), whereas over-
expression of Relish enhanced expression. SCA3 flies het-
erozygous for Relish expressed levels of Relish target
genes comparable to those expressing Relish RNAi con-
structs in the astrocytes. Dif/Dorsal-specific target genes
were unaffected by \modulating Relish levels in astrocytes
(Additional file 5). These data highlight the importance of
Relish signaling in astrocytes regarding Relish-dependent
immune signaling in the head.
The presence of aggregated or misfolded proteins is
toxic to neurons [32]. Possibly, astrocytes could have an
effect on levels of protein aggregates. To see whether
Relish-specific signaling in astrocytes could have an ef-
fect on solubility of SCA3polyQ78 in the eyes, we collected
heads of flies expressing eye-specific SCA3polyQ78 2 days
after eclosion and analyzed the cell extract. Modulating
Relish expression in astrocytes or heterozygosity for Rel-
ish did not affect total levels or solubility of SCA3polyQ78
(Fig. 3b, quantification of three independent experiments
in Fig. 3c). This suggests that the effect of Relish on
SCA3polyQ78-induced degeneration is not the result of ei-
ther a clearance of SCA3polyQ78 aggregates or of a shift
of the balance of soluble-insoluble SCA3polyQ78 towards
more soluble SCA3polyQ78.
To see whether Relish can modulate SCA3-induced eye
degeneration via Relish-dependent AMPs, we expressed
RNAi constructs targeting two Relish-dependent AMPs


































































































































































































































































Fig. 2 (See legend on next page.)
Li et al. Journal of Neuroinflammation  (2018) 15:261 Page 8 of 17
(AttA and CecA; efficacy of knockdown in
Additional file 6a). Astrocyte-specific downregulation of
these AMPs attenuated the degenerative SCA3 eye pheno-
type (Fig. 4a; quantification of degeneration in Fig. 4b),
similar to decreasing Relish activity in astrocytes (Fig. 2a, b).
No effect on eye morphology was seen when RNAi targeting
AMPs was expressed in astrocytes (Additional file 6b).
We next analyzed mCD8-GFP levels in the eyes as a
measure of degeneration in SCA3polyQ78-expressing eyes
and examined the effect of astrocyte-specific knockdown
of Relish-specific AMPs. Levels of mCD8-GFP were in-
creased upon knockdown of AMPs, demonstrating at-
tenuation of SCA3polyQ78-induced eye degeneration
(Fig. 4c; analysis on western blot and quantification of
three independent experiments in Fig. 4d). In control eyes,
no effects of downregulation of Relish-specific AMPs ex-
pression in astrocytes on mCD8-GFP levels in the eyes
were found (Additional file 6c). We also examined
whether astrocyte-specific knockdown of Relish-specific
AMPs could influence the presence of astrocytes in SCA3-
polyQ78-expressing eyes, but did not see an effect (Fig. 4c),
and the numbers of astrocytes were also not affected, as
analyzed by levels of myr-RFP in astrocytes (Fig. 4e).
When we examined the effect of astrocyte-specific
downregulation of AMPs on SCA3polyQ78 levels or solubil-
ity, we did not observe an effect (Fig. 4f; quantification of
three independent experiments), similar to modulating
Relish levels in astrocytes. These data show that the effect
of Relish on degeneration in our SCA3 model is, to a sig-
nificant extent, mediated via the generation of AMPs, and
that the effect of AMPs does not occur via alterations in
SCA3polyQ78 solubility.
We next tested whether the observed effects of the
Relish pathway in astrocytes on (short term) degeneration
also translates into a (long term) survival benefit in flies
expressing SCA3polyQ78 in neurons. Astrocyte-specific
Relish inhibition may also extend lifespan in neurons ex-
pressing SCA3polyQ78, given our observations of Relish in
astrocytes on the SCA3 eye phenotype. We expressed
SCA3polyQ78 pan-neuronally (not in astrocytes) and exam-
ined effects of modulation of Relish expression specifically
in astrocytes (specificity of expression shown in
Additional file 7a) using the following two independent
binary expression systems (Additional file 7b): UAS-Gal4
and QUAS-QF2. To avoid potential detrimental effects of
SCA3polyQ78 during development, we expressed SCA3po-
lyQ78 in adult flies only, using the inducible “Q system,” in
which the neuronally expressed transcription factor (QF2)
that induces SCA3polyQ78 expression is coexpressed with
QF-suppressor QS [20] (Additional file 7b). This way, ex-
pression of SCA3polyQ78 is suppressed during development
(Fig. 5a). Feeding quinic acid suppresses QS, thus alleviat-
ing inhibition of QF2 resulting in the neuron-specific ex-
pression of SCA3polyQ78, of which the extent of
aggregation increased over time (Fig. 5a). The lifespan of
flies expressing SCA3polyQ78 in neurons was significantly
shortened (Fig. 5b). Quinic acid by itself did not affect life-
span (Additional file 7c), excluding non-specific effects.
Relish-dependent gene expression was increased in flies
that expressed SCA3polyQ78 in neurons (Fig. 5c), similar to
expression of SCA3polyQ78 in the eyes (Fig. 2a).
We next wished to examine whether modulating
Relish levels in astrocytes in adult flies could have an
effect on lifespan of flies that expressed SCA3polyQ78
pan-neuronally. For this, levels of Relish were modulated
in astrocytes of adult flies to exclude effects on develop-
ment. Hereto, we used the transcription factor Gal4 to
drive the expression of the Relish constructs. At a lower
(See figure on previous page.)
Fig. 2 Effect of NF-κB transcription factor Relish in astrocytes on SCA3polyQ78-induced degeneration. a Quantification of Relish or Dif/Dorsal
activation in the head upon eye-specific expression of SCA3polyQ78. Heads of control flies or flies expressing SCA3polyQ78 in the eyes were analyzed
for expression of Relish target genes (CecA, DptA) or Dif/Dorsal target genes (IM-1, IM-2). b Effect of modulation of Relish expression in astrocytes
on SCA3polyQ78-induced eye degeneration. Representative images of fly eyes expressing SCA3polyQ78 (−) or SCA3polyQ78 together with either
astrocyte-specific expression of two independent RNAi constructs targeting Relish (Relish RNAi #1 and Relish RNAi #2), a Relish overexpression
construct (Relish overexpression) or flies heterozygous for Relish (Relish −/+). c Quantification of the fraction of degeneration of the eyes shown in
b. In these and other eye quantification experiments, at least 80 eyes of females were counted per genotype. Data are representative of at least
three independent experiments ± SEM. d The effect of modulation of Relish expression in astrocytes on GFP fluorescence in SCA3polyQ78-expressing
eyes together with eye-specific mCD8-GFP and on the localization of astrocytes (expressing myr-RFP). Representative images of control eyes, eyes
expressing mCD8-GFP, and astrocyte-specific myr-RFP (RFP) or together with coexpression of SCA3polyQ78 in the absence or presence of Relish
RNAi constructs (Relish RNAi #1 and Relish RNAi #2) or Relish overexpression in astrocytes. e Quantification of the effect of Relish signaling in
astrocytes on SCA3polyQ78-induced degeneration by using eye-specific expression of mCD8-GFP. Levels of mCD8-GFP were determined in lysates
of fly heads of flies expressing SCA3polyQ78 together with mCD8-GFP in the eyes and the effect of astrocyte-specific expression of Relish RNAi
constructs (Relish RNAi #1 and Relish RNAi #2) in astrocytes, heterozygosity for Relish (Relish −/+), or overexpression of Relish in astrocytes was
analyzed. Tubulin was used as a control for equal loading. Quantification of western blots is of at least three independent experiments. f Analysis
of myr-RFP expression in astrocytes in lysates of control flies or flies expressing myr-RFP in astrocytes together with eye-specific SCA3polyQ78 in the
presence or absence of astrocyte-targeted Relish RNAi (Relish RNAi #1 or #2) or Relish overexpression. Quantification of western blots in two
independent experiments. Genotypes: a control, GMR-QF2/+. SCA3polyQ78, GMR-QF2/+; QUAS- SCA3polyQ78/+. b, c -, GMR-QF2/+; QUAS-SCA3polyQ78:: alrm-
Gal4/+. Relish RNAi #1, GMR-QF2/+; QUAS-SCA3polyQ78:: alrm-Gal4/UAS-Relish RNAi #1. Relish RNAi #2, GMR-QF2/+; QUAS-SCA3polyQ78:: alrm-Gal4/UAS-Relish
RNAi #2. Relish overexpression, GMR-QF2/+; QUAS-SCA3polyQ78:: alrm-Gal4/UAS-GFP-Relish; Relish−/+, GMR-QF2/+; QUAS-SCA3polyQ78:: alrm-Gal4; Relish
E20/+. d–f As in b, but with additional eye-specific expression of QUAS-CD8-GFP or astrocyte-specific expression of UAS-myr-RFP
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temperature (18 °C), activity of Gal4 is low and Relish
RNAi constructs do not decrease Relish expression
(Additional file 7d). 4 days after eclosion, we induced
SCA3polyQ78 expression in neurons by adding quinic acid
to the food. Flies were shifted to 25 °C to induce expres-
sion of the Relish constructs in astrocytes. Importantly,
reducing Relish expression in astrocytes extended the
lifespan of SCA3 flies, whereas overexpression shortened
the lifespan (Fig. 5d). In control flies, downregulating
Relish expression in astrocytes had no effect on lifespan
(Additional file 7e), indicating that the effects of Relish
RNAi are linked to SCA3polyQ78-mediated degeneration of
neurons. However, overexpression of Relish alone in astro-













































































































































































































Fig. 3 Relish signaling in astrocytes influences SCA3polyQ78-induced gene expression but not the extent of SCA3 aggregation. a Analysis of the
effect of modulating Relish expression in astrocytes or Relish heterozygosity on Relish activity in heads of flies expressing SCA3polyQ78 in the eyes.
Expression of Relish target genes (DptA or AttC) was determined in heads of control flies (control) and flies expressing SCA3polyQ78 in the eyes.
The effect of Relish RNAi targeted to astrocytes (Relish RNAi #1 and Relish RNAi #2), Relish overexpression or heterozygosity for Relish (Relish −/+)
in flies expressing eye-specific SCA3polyQ78 was determined. b Lysates of fly heads described in (a) were analyzed on Western blot to determine levels of
soluble and aggregated HA-tagged SCA3polyQ78. c Quantification of the SDS-soluble/SDS-insoluble ratio of SCA3polyQ78 of three independent experiments
shown in b. n.s., not significant. Genotypes in a and b: control, GMR-QF/+; for other genotypes, see Fig. 2b












































































































































































































Fig. 4 (See legend on next page.)
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precluding analysis on Relish overexpression on SCA3po-
lyQ78-mediated shortening of lifespan.
In parallel, SCA3-related effects on motor function were
analyzed, measured as climbing ability. The SCA3poly-
Q78-induced decrease in climbing ability was partially
alleviated by knockdown of Relish in astrocytes
(Additional file 7f). As was observed with modulating Rel-
ish expression in astrocytes in SCA3polyQ78-expressing
eyes, no effects of Relish in astrocytes on total brain
SCA3polyQ78 aggregation load or levels could be detected
(Additional file 7g).
The effects of Relish modulation on SCA3-related de-
generation were not related to alterations of the levels of
SCA3polyQ78 aggregates (Fig. 3b and Additional file 7g).
Therefore, we hypothesized that modulation of the Rel-
ish pathway in astrocytes could be more generic and
relevant to a neurodegenerative disease associated with
the presence of extraneuronal aggregates, such as in
Alzheimer’s disease. For this, we turned to an established
Drosophila model of Alzheimer’s disease [18], in which
the Amyloid beta (Abeta42; Aβ42) peptides are fused to
a secretion signal peptide (of the necrotic gene), resulting
in the secretion of Aβ42 peptides. When expressed in
neurons (Additional file 7h), these Aβ42 peptides are se-
creted and form extracellular aggregates in flies, reminis-
cent of the plaques in human AD [33]. In this AD fly
model, flies displayed progressive neurodegeneration,
with mobility and memory deficits, and reduced lifespan
[18, 34]. In line with our hypothesis, the lifespan of flies
expressing Aβ42 in neurons was shortened, but ex-
tended when Relish expression was suppressed in astro-
cytes, using two independent RNAi lines targeting Relish
(Fig. 5e). This, together with the data on SCA3, demon-
strates that modulating Relish signaling in astrocytes has
beneficial effects in neurodegeneration, irrespective of
the aggregation process that initiates it.
Our data show that astrocytes can modulate the rate
of neurodegenerative disease progression in a cell-non-
autonomous manner. This is the first time to show that
neuron-specific expression of a pathological,
degeneration-inducing protein results in activation of
astrocytes, which can subsequently influence symptoms
of degeneration.
Discussion
Astrocytes become reactive during the course of a number
of age-related neurodegenerative diseases associated with
aggregates [6], and several reports have suggested that
during the course of disease astrocytes gain neurotoxic
properties ([4] reviewed in [6]). However, potential mecha-
nisms for how astrocytes affect progression of disease have
yet been lacking, in part due to the fact that in most stud-
ies disease-causing genes are expressed in both neuronal
and non-neuronal cells in the brain. Expression of
aggregation-prone proteins in astrocytes can cell-non-au-
tonomously influence neuronal viability [5], reviewed in
[6]. However, putative cell-non-autonomous contributions
of astrocytes to neurodegeneration in response to neurons
expressing aggregation-prone proteins are unclear. Here,
we investigate how signaling in astrocytes can influence
neurons that express aggregation-prone, disease-causing
proteins, thus investigating cell-non-autonomous contri-
butions of astrocytes to neurodegeneration. We identified
astrocytes in Drosophila eyes expressing SCA3polyQ78 but
not in control eyes or eyes expressing SCA3polyQ27
(Fig. 1d), suggesting a role for astrocytes. We further in-
vestigated putative cell-non-autonomous contributions of
genes in astrocytes in a candidate RNAi screen, where the
effect of RNAi-mediated downregulation of individual
genes in astrocytes on SCA3polyQ78-induced eye degener-
ation was determined. This resulted in the identification
of astrocyte-specific enhancers and suppressors of the
SCA3-related neurodegeneration (Additional file 3). These
results demonstrate, for the first time, the importance of
signaling in astrocytes induced by specific expression of
aggregation-prone, neurodegeneration-associated proteins.
(See figure on previous page.)
Fig. 4 Relish target genes influence SCA3polyQ78-induced degeneration but not SCA3polyQ78 aggregation or SCA3polyQ78-induced relocation of
astrocytes. a Representative images of flies expressing eye-specific SCA3polyQ78 compared to flies coexpressing RNAi constructs in astrocytes
targeting Relish target genes AttA or CecA. b Quantification of the fraction of degeneration of the eyes shown in a. Data are representative of at
least three independent experiments. c Representative images of the effect of downregulation of Relish target genes AttA or CecA in astrocytes
on SCA3-induced degeneration or the relocation of astrocytes upon expression of eye-specific SCA3polyQ78 by using eye-specific expression of
mCD8-GFP and astrocyte-targeted expression of myr-RFP (RFP). d Quantification of the effect of Relish target genes in astrocytes on SCA3-induced
degeneration by using membrane-targeted mCD8-GFP. Lysates of fly heads expressing mCD8-GFP and SCA3polyQ78 in the eyes were analyzed on
western blot and compared to flies coexpressing RNAi constructs targeting AttA or CecA in astrocytes. Quantifications are of at least three independent
experiments. e No effect on Relish target genes on levels of astrocytes expressing myr-RFP. Lysates of fly heads of control flies or flies expressing
myr-RFP in astrocytes together with SCA3polyQ78 in the eyes in the presence or absence or AMP RNAi constructs (AttA RNAi or CecA RNAi) were
analyzed on western blot for expression for myr-RFP and tubulin. Quantifications are of two independent experiments. f Analysis of the effect of Relish
target genes in astrocytes on SDS-solubility of SCA3polyQ78 expressed in the eyes. Head lysates of flies expressing HA-tagged SCA3polyQ78 in the eyes
were compared to flies coexpressing RNAi constructs targeting AttA or CecA in astrocytes. Quantifications of the SDS-soluble/SDS-insoluble ratio are of
at least three independent experiments. Genotypes a -: GMR-QF2/+; QUAS-SCA3polyQ78:: alrm-Gal4/+. AttA RNAi, GMR-QF2/+; QUAS-SCA3polyQ78:: alrm-
Gal4/UAS-AttA RNAi. CecA RNAi, GMR-QF2/+; QUAS-SCA3polyQ78:: alrm-Gal4/+; UAS-CecA RNAi/+. c, d Con: GMR-QF2/+, the rest of the genotypes as in a
but with coexpression of QUAS-mCD8-GFP or UAS-myr-RFP. e, f Con: GMR-QF2/+; other samples as in a
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Fig. 5 (See legend on next page.)
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Astrocytes in Drosophila share structural and functional
similarities with mammalian astrocytes: amongst others,
they provide trophic support to neurons and are involved
in neurotransmitter recycling (reviewed in [35]). Therefore,
genes that we identified in our screen may be relevant for
mammalian astrocytes as well.
Conserved NF-κB transcription factor Relish was iden-
tified as an enhancer in our SCA3 model, and its activity
was upregulated in the head upon eye-specific SCA3po-
lyQ78 expression. We therefore focused on Relish signal-
ing for more in-depth analyses. Relish was specifically
activated in astrocytes present in eyes expressing SCA3-
polyQ78, but not in astrocytes elsewhere in the head
(Additional file 4a). Downregulation of expression in as-
trocytes of both Relish, but also Relish-dependent AMPs
alleviated SCA3polyQ78-induced eye degeneration (Figs. 2
and 4). In contrast, we did not see an effect of downreg-
ulation of Relish expression on degeneration in eyes
coexpressing SCA3polyQ78 and Relish RNAi constructs
(Additional file 4d). Thus, eye-specific expression of
aggregation-prone SCA3polyQ78 results in cell-non-au-
tonomous activation of NF-κB in astrocytes. We next in-
vestigated possible cell-non-autonomous contributions
of astrocytes to neurodegeneration.
Downregulation of Relish expression in astrocytes not
only delayed neurodegeneration (suggested by enhanced
mobility, Additional file 7f) and extended lifespan of flies
expressing SCA3polyQ78 in neurons (Fig. 5d), but also ex-
tended lifespan in flies expressing neuronal Aβ42 peptides
(Fig. 5e). We did not see an effect of downregulating Rel-
ish expression in astrocytes on lifespan (Additional file 7e),
underscoring the efficacy of using this pathway as a target
to inhibit the detrimental effects of SCA3polyQ78. However,
overexpression of Relish in astrocytes was sufficient to
shorten lifespan, demonstrating toxic effects of Relish.
This is in agreement with earlier studies demonstrating
that expression of Relish or Relish-specific AMPs was
sufficient to induce neurodegeneration [30, 36]. Of par-
ticular interest is that in aging flies Relish activity and
levels of AMPs were increased in both neurons and glia,
and constitutes an important determinant of lifespan con-
trol and the onset of neurodegeneration [31]. In addition
to this, our data demonstrate the importance of
cell-non-autonomous Relish signaling in astrocytes in
neurodegeneration associated with aggregates, which is
generally aging-associated. The presence of aggregation-
prone, neurodegeneration-associated proteins in neurons
resulted in Relish signaling in astrocytes, which subse-
quently influenced neuronal functioning. Together, these
findings suggest the importance of NF-κB activity in astro-
cytes in age-associated neurodegenerative diseases.
Our data thus provide direct evidence for earlier
suggestions that astrocytes are not only activated in re-
sponse to neurodegeneration (as, e.g., demonstrated by
elevation of GFAP, glial fibrillary acidic protein, a marker
for astrocyte activation) [5], but indeed can modulate
disease progression. The relevance of the cell-non-au-
tonomous Relish activation in astrocytes is underscored
by the observation that downregulation of Relish in as-
trocytes can influence disease progression. A toxic gain
of function in astrocytes was also demonstrated in a
mice expressing human aggregation-prone TAR DNA-
binding protein 43 (TDP-43) in neurons [37], resulting
in alterations in protein expression in astrocytes.
Depletion of an upregulated, astrocyte-specific factor re-
duced neurotoxicity, underscoring the importance of as-
trocytes to neurotoxicity. Our findings that genes in the
NF-κB pathway are key mediators of such a response ex-
tends the observation that astrocyte-specific, transient
expression of IKK (IκB kinase 2), resulted in neurode-
generation in mice [38].
While Lattke et al. showed sufficiency of astrocyte-spe-
cific NF-κB signaling in inducing neurodegeneration,
our data now demonstrate that signals from neurons
(See figure on previous page.)
Fig. 5 Analysis of SCA3polyQ78 expression in neurons and the effect of Relish in astrocytes on neuronal expression of SCA3polyQ78 or Abeta42. a
Inducible expression of SCA3polyQ78 in neurons can be suppressed during development. Control larvae or larvae expressing inducible SCA3polyQ78
were cultured on food with and without quinic acid. Flies expressing inducible SCA3polyQ78 were cultured on food with quinic acid for the times
indicated to induce SCA3polyQ78 expression. Levels and aggregation of HA-tagged SCA3polyQ78 were determined in lysates of larvae or fly heads on
western blot. Tubulin was used to verify equal loading. b Effect of inducible SCA3polyQ78 on lifespan. Control flies or 4-day-old flies expressing
inducible SCA3polyQ78 were cultured on food containing quinic acid and the lifespan was analyzed. c Expression of Relish target genes AttC, DptA
and CecA was analyzed in heads of 15-day-old flies expressing SCA3polyQ78 in neurons. d Analysis of modulation of Relish expression specifically in
astrocytes on the lifespan of flies expressing SCA3polyQ78 in neurons. Flies expressing SCA3polyQ78 in neurons induced as in b were compared to
flies coexpressing astrocyte-targeted Relish RNAi (Relish RNAi #1 or #2) or overexpressing Relish in astrocytes. To induce changes in Relish expression only in
adult flies, crosses were kept at 18 °C. 4-day-old progeny were shifted to 25 °C to allow expression of Relish constructs in astrocytes. e Downregulation of
Relish expression in astrocytes extends lifespan in an Alzheimer model. Lifespan of control flies and flies expressing Abeta42 in neurons were compared to
flies expressing Abeta42 (Aβ42) in neurons and Relish RNAi constructs in astrocytes. Induction of Relish RNAi was done as in d. Genotypes: a -, tub-QS/+;
alrm-Gal4/+; nSyb-QF2::tub-QS/+. SCA3polyQ78, tub-QS/+; alrm-Gal4::QUAS-SCA3polyQ78/+; nSyb-QF2::tub-QS/+. b, c Control, tub-QS/+; alrm-Gal4/+;
nSyb-QF2::tub-QS/+. SCA3polyQ78, tub-QS/+; alrm-Gal4::QUAS-SCA3polyQ78/+; nSyb-QF2::tub-QS/+. d -, tub-QS/+; alrm-Gal4/+; nSyb-QF2::tub-QS/+.
SCA3polyQ78, tub-QS/+; alrm-Gal4::QUAS-SCA3polyQ78/+; nSyb-QF::tub-QS/+; Relish RNAi #1, Relish RNAi #2, or Relish overexpression, as in SCA3polyQ78, but
with expression of UAS-Relish RNAi #1 or #2 or UAS-GFP-Relish in astrocytes. e -, alrm-Gal4/+; nSyb-QF2. Aβ42: alrm-Gal4::QUAS-Abeta42/+; nSyb-QF2/+.
Relish RNAi (#1 or #2), alrm-Gal4:: QUAS-Abeta42/UAS-Relish RNAi #1 or #2); nSyb-QF2/+
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expressing aggregation-prone proteins suffice to induce
cell-non-autonomous NF-κB activation in astrocytes.
The importance of NF-κB activation in astrocytes was
suggested by date presented in Fig. 3a and
Additional file 5a. The presence of astrocytes in
SCA3polyQ78-expressing eyes (Fig. 1d, Additional file 4)
suggests recruitment of astrocytes, as shown for Alzhei-
mer’s disease (reviewed in [39]). Downregulation of NF-κB
in astrocytes did not appear to alter the presence of
astrocytes in SCA3polyQ78-expressing eyes (Fig. 2d,
Additional file 4e), suggesting that additional signaling in
astrocytes promotes the recruitment of astrocytes to de-
generating cells. Together, these data demonstrate the ex-
istence and importance of intercellular signaling between
neurons and astrocytes as an important determinant for
the speed of neurodegeneration.
The nature of the neuronal signals that trigger NF-κB
activation in astrocytes remains to be elucidated. Possibly,
damage-associated molecular patterns (DAMPs), includ-
ing SCA3polyQ78 aggregates, released from neurons can re-
sult in activation of NF-κB in astrocytes. It is unlikely that
the Relish canonical pathway, headed by PGRP-LC
(reviewed in [27]), accounts for Relish activation, since
modulation of PGRP-LC did not significantly affect the
SCA3 eye phenotype (Additional file 1). Previous reports
have demonstrated Relish activation independent of
PGRP-LC, either by neuropeptides or nitric oxide [40, 41],
which may account for Relish activation in our model.
Whereas we show that astrocytes can directly modu-
late neuronal health, this appeared not to be associated
with alteration in the burden of protein aggregates in
the brain. However, decreasing the levels of misfolded or
aggregated proteins has been suggested as a therapeutic
strategy [42]. Furthermore, reduction of oxidative
damage can decrease degeneration [43]. Thus, a combin-
ation of therapeutic strategies targeting aggregates,
astrocyte-mediated neurotoxicity as well as oxidative
damage may have optimal effects in alleviating
aggregates-associated neurodegeneration.
Targeting NF-κB signaling in astrocytes to alleviate
neurodegeneration may be more broadly applicable: the
lifespan of flies expressing Aβ peptides, present in pa-
tients with AD, was extended upon astrocyte-specific in-
hibition of NF-κB (Fig. 5e). Thus, despite intracellular
localization of aggregates in SCA3 and extracellular
localization of Aβ peptides in AD, astrocyte-specific
NF-κB inhibition extended lifespan in fly models for
both diseases. This suggests that targeting NF-κB in as-
trocytes may be beneficial in other aggregates-associated
neurodegenerative diseases.
Conclusion
In conclusion, our data demonstrate that astrocytes re-
spond to cellular stress or damage in neurons induced by
neuronal expression of disease-associated, aggregation-
prone proteins. These astrocytic responses are important
modulators of neurodegeneration. We demonstrate that
activation of transcription factor NF-κB Relish occurs in
astrocytes in response to proteotoxic stress in neurons,
and that in this situation astrocyte-specific inhibition of
Relish enhances vitality and extends lifespan. While pro-
teotoxic stress in astrocytes can contribute to neurodegen-
eration, these data highlight the importance of astrocytic
responses to cellular stress or damage in neurons, and
provide putative therapeutic potential.
Additional files
Additional file 1: Genetic setup to analyze cell-non-autonomous or
cell-autonomous roles of genes to SCA3. a To model SCA3 in Drosophila
eyes, we used the Q (QUAS-QF) system, in which a QUAS-SCA3polyQ78
(or QUAS-SCA3polyQ27) construct was induced by QF2 specifically expressed
in the eyes, GMR-QF2. To downregulate gene expression in astrocytes,
we used the UAS-Gal4 system. UAS-RNAi constructs were specifically
expressed in astrocytes by using a Gal4 expressed in astrocytes, alrm-Gal4.
Cell-autonomous roles of genes in SCA3 can be analyzed by coexpressing
UAS-SCA3polyQ78 with UAS constructs in the eye, using eye-specific GMR-Gal4.
b Independent expression of the QUAS-QF2 system (GFP in the eyes) and
the UAS-Gal4 system (RFP in astrocytes) in late pupa. Genotype, GMR-QF2/+;
alrm-Gal4/UAS-myr-RFP; QUAS-mCD8-GFP/+. (PDF 186 kb)
Additional file 2: Analysis of localization of astrocytes induced by eye-
specific expression of SCA3polyQ78. The eyes of control flies that express
myr-RFP in astrocytes in the absence or presence of SCA3polyQ27 or SCA3-
polyQ78 were analyzed for expression and localization of RFP. Genotypes:
control, GMR-QF2/+; alrm-Gal4::UAS-myr-RFP/+. SCA3polyQ27, GMR-QF2/+;
alrm-Gal4::UAS-myr-RFP/QUAS-SCA3polyQ27. SCA3polyQ78, GMR-QF2/+; alrm-
Gal4::UAS-myr-RFP/QUAS-SCA3polyQ78. (PDF 4177 kb)
Additional file 3: RNAi screen to determine the contribution of genes
in astrocytes to SCA3polyQ78-induced eye degeneration. Flies expressing
SCA3polyQ78 in the eyes together with alrm-Gal4 were crossed to fly lines
containing UAS-RNAi constructs to specifically knock down genes in
astrocytes. Progeny expressing SCA3polyQ78 in the eyes with individual
genes in astrocytes knocked down were analyzed for SCA3polyQ78-
induced eye degeneration. The extent of degeneration was quantified
and plotted in a table. The percentage of degeneration in SCA3polyQ78
eyes was set at 100% and the effect of RNAi-mediated gene knockdown
in astrocytes was determined by the percentage of deviation from the
control. The suppressors of degeneration (in which RNAi-induced down-
regulation of gene expression in astrocytes enhanced the SCA3polyQ78
phenotype, 60% or more deviation from the control) are shown in
orange, the enhancers (40% or more deviation from the control) in
purple. Genotype of the crosses SCA3polyQ78, GMR-QF2/+; QUAS-SCA3polyQ78:: alrm-
Gal4/+. RNAi: GMR-QF2/+; QUAS-SCA3polyQ78:: alrm-Gal4/+ together with UAS-
RNAi. (PDF 149 kb)
Additional file 4: a Activation of Relish in SCA3polyQ78-expressing eyes
predominantly occurred in astrocytes. (top) Representative picture of a
control eye expressing GFP under the control of the Attacin promoter
(att-GFP) and astrocytes expressing RFP or an eye coexpressing SCA3polyQ78.
Pictures were taken from live eyes. (bottom) Representative picture of a
dissected eye expressing SCA3polyQ78, together with att-GFP and
RFP-expressing astrocytes. Nuclei are stained with Hoechst (blue). Note
that in the bottom panel there is only an overlap between the RFP and
GFP signal in the ommatidia. This may cause the imperfect overlap
between the RFP and GFP signal in SCA3polyQ78-expressing flies in the
top panel: the RFP signal from the underlying astrocytes. b Efficacy of Relish
knockdown. Flies expressing daughterless-Gal4 (da-Gal4, ubiquitously
expressed) were crossed to control flies (w1118) or fly lines containing RNAi
constructs targeting Relish (Relish RNAi #1 and Relish RNAi #2) and
expression of Relish in the progeny was determined. c Modulation of
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expression in astrocytes does not affect morphology of control eyes.
Control flies or fly lines containing RNAi constructs targeting Relish (Relish
RNAi #1 and Relish RNAi #2) or expressing Relish were crossed to alrm-Gal4
flies, and the morphology of the eyes was determined. d No cell-
autonomous effect of Relish on the degenerative SCA3polyQ78 eye pheno-
type. Constructs targeting Relish were coexpressed in the eyes expressing
SCA3polyQ78. e Expression of Relish RNAi in astrocytes does not influence the
relocation of the astrocytes to the eye induced by eye-specific expression of
SCA3polyQ78. Images of multiple flies to show similar levels of RFP in the
eyes between flies expressing eye-specific of SCA3polyQ78 and astrocyte-
specific myr-RFP (RFP) in the absence or presence of Relish RNAi targeted to
astrocytes. f Modulating Relish expression in astrocytes does not affect levels
of mCD8-GFP in the eyes. Lysates of fly heads expressing eye-specific
mCD8-GFP were compared to fly heads expressing eye-specific mCD8-GFP
together with astrocyte-specific knockdown or overexpression of Relish
constructs or flies heterozygous for Relish (Relish −/+). Analysis of the
mCD8-GFP/tubulin ratio of two independent experiments is shown below.
Genotypes a control, GMR-QF2/+; alrm-Gal4::UAS-myr-RFP; att-GFP/+. SCA3po-
lyQ78, GMR-QF2/+; alrm-Gal4::UAS-myr-RFP::QUAS-SCA3polyQ78; att-GFP/+. b
Control, da-Gal4/+. Relish RNAi #1, UAS-Relish RNAi #1/+; da-Gal4/+. Relish
RNAi #2, UAS-Relish RNAi #2/+; da-Gal4/+. c Control, alrm-Gal4/+. Relish RNAi
#1, alrm-Gal4/UAS-Relish RNAi#1. Relish RNAi #2, alrm-Gal4/+; UAS-Relish
RNAi#2/+. GFP-Relish: alrm-Gal4/UAS-GFP-Relish. d -, GMR-Gal4::UAS-SCA3po-
lyQ78/+. Relish RNAi#1, GMR-Gal4:: UAS-SCA3polyQ78/UAS-Relish RNAi#1. Relish
RNAi#2, GMR-Gal4::UAS-SCA3polyQ78/UAS-Relish RNAi #2. Relish overex-
pression, GMR-Gal4::UAS-SCA3polyQ78/UAS-GFP-Relish. e As in Fig. 2d. f -,
GMR-QF2/+; alrm-Gal4/+ QUAS-mCD8-GFP. Relish RNAi #1, GMR-QF2/+;
alrm-Gal4/UAS-Relish RNAi #1; QUAS-mCD8-GFP/+. Relish RNAi #2, GMR-
QF2/+; alrm-Gal4/UAS-Relish RNAi #2; QUAS-mCD8-GFP/+. Relish−/+,
GMR-QF2/+; alrm-Gal4; Relish E20/QUAS-mCD8-GFP. Relish overexpression,
GMR-QF2/+; QUAS- SCA3polyQ78:: alrm-Gal4/UAS-Relish QUAS-mCD8-GFP.
(PDF 1700 kb)
Additional file 5: Effect of modulating Relish levels in astrocytes on
Dif/Dl-dependent gene expression in the head. Expression of Dif/Dl target
genes (IM1 or IM2) was determined in the heads of control flies (control),
flies expressing SCA3polyQ78 in the eyes (-), and the effect of Relish RNAi
targeted to astrocytes (Relish RNAi #1 and Relish RNAi #2), Relish
overexpression, or SCA3polyQ78-expressing flies heterozygous for Relish
(Relish −/+) on Dif/Dl target gene expression was determined by
comparing them to flies only expressing SCA3polyQ78. (PDF 125 kb)
Additional file 6: a Efficacy of knockdown of CeCA or AttA gene
expression. Flies expressing daughterless-Gal4 (da-Gal4) were crossed to
control flies (w1118) or fly lines containing RNAi constructs targeting AttA
or CecA and expression of CeCA or AttA in the adult progeny was
determined. b Downregulating in astrocytes does not affect eye
morphology. Control flies or fly lines containing RNAi constructs targeting
CeCA or AttA were crossed to alrm-Gal4 flies and the morphology of the
eyes was determined. c No effect of modulating of Relish-dependent AMP
expression in astrocytes on mCD8-GFP levels in the eyes. Flies expressing
eye-specific mCD8-GFP were compared to flies coexpressing RNAi constructs
targeting AttA or CecA in astrocytes. Genotypes (a): control, da-Gal4/+. AttA,
UAS− AttA/+ da-Gal4/+; CecA, UAS- CecA/+; da-Gal4/+. (b) Control, alrm-Gal
4/+. AttA RNAi, alrm-Gal 4/UAS-AttA RNAi. CecA RNAi, alrm-Gal 4/+; UAS-CecA
RNAi/+. (c) As in (b), but with coexpression of QUAS-mCD8-GFP. (c) Control:
GMR-QF2/+; alrm-Gal4/+; QUAS-mCD8GFP/+. AttA RNAi, GMR-QF2/+; alrm-
Gal4/UAS-AttA RNA; QUAS-mCD8GFP/+. CecA RNAi, GMR-QF2/+; alrm-Gal4/+;
UAS-CecA RNAi/QUAS-mCD8GFP. (PDF 289 kb)
Additional file 7: a The UAS-Gal4 and the QUAS-QF system function
independently. QUAS-QF-driven GFP expression specifically in neurons
(GFP); UAS-Gal4-driven expression of myr-RFP specifically in astrocytes
(RFP). Nuclei are stained with Hoechst (blue). b Genetic setup to inducibly
express SCA3polyQ78 in neurons and simultaneously modulate gene
expression in astrocytes. QUAS-QF was used to express SCA3polyQ78;
UAS-Gal4 was used to modulate expression in astrocytes. Neuronally
expressed QF2 (expressed under control of the pan-neuronal nSyb pro-
moter) is suppressed by QS (expressed under control of the tubulin (tub)
promoter). This suppression is alleviated by quinic acid, resulting in
expression of SCA3polyQ78. For details on the fly lines used, see experimental
procedures. c Quinic acid does not affect lifespan. Control flies were
cultured on standard fly food with or without quinic acid, and the fraction
of dead flies was determined over time. d Raising flies at 18 °C does not in-
duce expression of Relish RNAi constructs. Progeny of flies ubiquitously ex-
pressing RNAi constructs targeting Relish (Relish RNAi #1 and Relish RNAi #2)
raised at 18 °C were analyzed for expression of Relish as in Additional file 4b.
e Effect of modulating expression of Relish in astrocytes on lifespan. The
lifespan of control flies or flies expressing Relish RNAi or overexpression
constructs specifically in astrocytes was analyzed. f Effect of modulating
Relish expression in astrocytes on impairment of mobility induced by
neuronal SCA3
polyQ78
expression. Control flies or flies expressing inducible
SCA3
polyQ78
together with Relish RNAi or Relish overexpression constructs
targeted to astrocytes were analyzed for mobility over time. Scoring was
done as described in the experimental procedures. g Effect of modulating
Relish expression in astrocytes on SCA3
polyQ78
levels or aggregation. Head
lysates of 15-day-old flies as in Fig. 5c were analyzed for expression of
HA-tagged SCA3
polyQ78
on western blot. Tubulin was used as a control for
equal loading. h Expression levels of Abeta42. Two independent lines,
QUAS-Abeta42 #5 and QUAS-Abeta42 #7 were analyzed for expression of
Abeta42 using 6E10 antibody. Tubulin was used as a control for equal
loading. Genotypes: a alrm-Gal4::UAS-myr-RFP; nSyb-QF2/QUAS-mCD8-GFP. c
tub-QS/+; alrm-Gal4/+; nSyb-QF2::tub-QS/+. d Genotypes as in Additional file
4b. (e) -, tub-QS/+; alrm-Gal4/+; nSyb-QF2: tub-QS/+. Relish RNAi #1, Relish
RNAi #2, or Relish overexpression, as in ‘-‘, but with UAS-Relish RNAi #1 or #2
or UAS-GFP-Relish. f Genotypes as in Fig. 5d. g As in e. h Control, nSyb-QF2/
+. Abeta42 #5 or #7, QUAS-Abeta42/+; nSyb-QF2/+. (PDF 609 kb)
Abbreviations
AD: Alzheimer’s disease; AMPs: Antimicrobial peptides; HD: Huntington’s
disease; NF-κB: Nuclear factor kappa B; PBS: Phosphate-buffered saline;
SCA3: Spinocerebellar ataxia type 3; SDS-PAGE: Sodium dodecyl sulfate
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